Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the (cost)effectivity of Equine assisted Therapy in adolescents with Autism Spectrum disorders.
The study has a mixed-methods strategy consisting of three elements: a randomized, multiple-baseline single-case design (n=35), a qualitative study (n=8-10) and a cost-effectiveness study (n=6). After obtaining written informed consent, participants will be randomly assigned to one of the five pre-defined baseline lengths (2-6 weeks) to increase the internal validity of the design.
Age
11 - 18 years
Sex
ALL
Healthy Volunteers
No
Karakter
Ede, Gelderland, Netherlands
Horses & Co
Heerjansdam, Netherlands
De Gagelhoeve
Mill, Netherlands
Start Date
February 14, 2022
Primary Completion Date
December 1, 2024
Completion Date
December 1, 2024
Last Updated
November 4, 2024
35
ESTIMATED participants
Equine assisted Therapy (EAT)
BEHAVIORAL
Lead Sponsor
Karakter Kinder- en Jeugdpsychiatrie
Collaborators
NCT06290258
NCT05750095
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05874466